Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/65654
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTaweepoke Angkawanishen_US
dc.contributor.authorMirjam Nielenen_US
dc.contributor.authorHans Vernooijen_US
dc.contributor.authorJanine L. Brownen_US
dc.contributor.authorPeter J.S. Van Kootenen_US
dc.contributor.authorPetra B. Van Den Doelen_US
dc.contributor.authorWillem Schaftenaaren_US
dc.contributor.authorKannika Na Lampangen_US
dc.contributor.authorVictor P.M.G. Ruttenen_US
dc.date.accessioned2019-08-05T04:38:14Z-
dc.date.available2019-08-05T04:38:14Z-
dc.date.issued2019-03-13en_US
dc.identifier.issn1743422Xen_US
dc.identifier.other2-s2.0-85062878110en_US
dc.identifier.other10.1186/s12985-019-1142-8en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85062878110&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/65654-
dc.description.abstract© 2019 The Author(s). Background: Elephant endotheliotropic herpesviruses (EEHV) can cause an acute highly fatal hemorrhagic disease in young Asian elephants (Elephas maximus), both ex situ and in situ. Amongst eight EEHV types described so far, type 1 (subtype 1A and 1B) is the predominant disease-associated type. Little is known about routes of infection and pathogenesis of EEHV, and knowledge of disease prevalence, especially in range countries, is limited. Methods: A large cross-sectional serological survey was conducted in captive elephants (n = 994) throughout Thailand using an EEHV-1A glycoprotein B protein antigen specific antibody ELISA. Results: Antibody seroprevalence was 42.3%, with 420 of 994 elephants testing positive. Associations between seropositivity and potential risk factors for EEHV infection were assessed and included: elephant age, sex, camp cluster size, management type (extensive versus intensive), sampling period (wet vs. dry season) and location of camp (region). Univariable regression analysis identified management system and region as risk factors for the presence of EEHV antibodies in elephants, with region being significant in the final multivariable regression model. Prevalence was highest in the North region of the country (49.4%). Conclusions: This study produced baseline serological data for captive elephants throughout Thailand, and showed a significant EEHV burden likely to be maintained in the captive population.en_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleEvidence of high EEHV antibody seroprevalence and spatial variation among captive Asian elephants (Elephas maximus) in Thailanden_US
dc.typeJournalen_US
article.title.sourcetitleVirology Journalen_US
article.volume16en_US
article.stream.affiliationsDepartement Gezondheidszorg Landbouwhuisdieren, Universiteit Utrechten_US
article.stream.affiliationsDepartement Infectieziekten en Immunologie, Universiteit Utrechten_US
article.stream.affiliationsErasmus University Medical Centeren_US
article.stream.affiliationsUniversiteit van Pretoriaen_US
article.stream.affiliationsConservation Biology Instituteen_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsNational Elephant Instituteen_US
article.stream.affiliationsVeterinary Servicesen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.